Wright Medical price target raised to $35 from $32 at Piper Jaffray

Piper Jaffray analyst Matt O’Brien raised his price target for Wright Medical to $35 saying the company posted a Q3 beat with upper extremity outperformance. Further, the lower extremity business continues to “rebound nicely,” showing an acceleration in total ankles up 22% and the core segment demonstrating further market-rate-growth with increased sales force productivity, O’Brien tells investors in a post-earnings research note. He encourages investors to start positions in the name and reiterates an Overweight rating on Wright Medical.
https://thefly.com/landingPageNews.php?id=2820157